Pancreatic Cancer Research

ResearcherBeijing University of Chinese MedicineNo recent work listed

Jing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9964-1868; OpenAlex author ID A5045420183. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

  1. Pancreatic cancer progression and mortality predicted by depression and anxiety: a systematic review and meta-analysis protocol. First author DOI 10.3389/fpsyt.2023.1266502↗
  2. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics. Co-author DOI 10.1155/2022/4651432↗
  3. Efficacy and safety of traditional Chinese medicine for the treatment of pancreatic cancer: An overview of systematic reviews and meta-analyses. Co-author DOI 10.3389/fphar.2022.896017↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peitong Zhang · 3 shared papers, 2022–2023 · strength 0.64
  2. Ruoqi Zhang · 2 shared papers, 2022–2023 · strength 0.44
  3. Rui Miao · 1 shared paper, 2023 · strength 0.24
  4. Jie He · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.